S9511: A Southwest Oncology Group Phase II Study of Trimetrexate, 5FU, and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach

OBJECTIVE: The primary objective of this trial was to evaluate the response rate for trimetrexate (TMTX) in conjunction with 5FU and leucovorin (LV) (=TFL) in the treatment of advanced gastric cancer in a phase II, cooperative group setting. METHODS: Patients with locally advanced, unresectable, or...

Full description

Saved in:
Bibliographic Details
Main Authors: Blanke, Charles D., Chansky, Kari, Christman, Kathy L., Hundahl, Scott A., Issell, Brian F., Van Veldhuizen, Peter J., Budd, G Thomas, Abbruzzese, James L., Macdonald, John S.
Format: Artigo
Language:Inglês
Published: 2010
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2967385/
https://ncbi.nlm.nih.gov/pubmed/19770625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0b013e318199fb84
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items